{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05050149",
            "orgStudyIdInfo": {
                "id": "PALV-06"
            },
            "organization": {
                "fullName": "Palvella Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations",
            "officialTitle": "A Multicenter, Phase 2, Open-Label Study Evaluating The Safety And Efficacy of Sirolimus 3.9% Topical Gel (PTX-022) In The Treatment of Microcystic Lymphatic Malformations",
            "therapeuticArea": [
                "Other"
            ],
            "study": "study-evaluating-the-safety-and-efficacy-of-ptx-qtorin-sirolimus-in-the-treatment-of-microcystic-lymphatic-malformations"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-09-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2022-11-15",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2022-12-15",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-09-08",
            "studyFirstSubmitQcDate": "2021-09-17",
            "studyFirstPostDateStruct": {
                "date": "2021-09-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-08-26",
            "lastUpdatePostDateStruct": {
                "date": "2022-08-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Palvella Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study evaluates the safety and efficacy of PTX-022 (sirolimus) Topical Gel 3.9% w/w in the treatment of Microcystic Lymphatic Malformations. The participant will receive 3 months of PTX-022 treatment by the end of the study."
        },
        "conditionsModule": {
            "conditions": [
                "Microcystic Lymphatic Malformation"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "This is an open-label study",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 15,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Experimental: PTX-022",
                    "type": "EXPERIMENTAL",
                    "description": "PTX-022 QTORIN",
                    "interventionNames": [
                        "Drug: PTX-022"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "PTX-022",
                    "description": "Safety and Efficacy of PTX-022 in the Treatment of Microcystic Lymphatic Malformations",
                    "armGroupLabels": [
                        "Experimental: PTX-022"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of Treatment-Emergent Adverse Events",
                    "timeFrame": "4 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in clinician global assessment from Baseline to Month 4",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Change in patient global assessment from Baseline to Month 4",
                    "timeFrame": "4 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Participants must be 13 years or older\n* Diagnosed with Microcystic Lymphatic Malformations\n* Able and willing to comply with all protocol-required activities\n* Willing and able to provide written informed consent\n\nExclusion Criteria:\n\n* Any significant concurrent condition that could adversely affect participation.\n* Any history of allergy or hypersensitivity to sirolimus, or sirolimus-like medications or to PTX-022\n* Patient's deemed by the investigator as unwilling or unable to remain compliant with all tests and procedures, including adherence to study drug administration and other protocol-required activities.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "13 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Emily Cook",
                    "role": "CONTACT",
                    "phone": "484-253-1463",
                    "email": "emily.cook@palvellatx.com"
                }
            ],
            "locations": [
                {
                    "facility": "Arkansas Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Little Rock",
                    "state": "Arkansas",
                    "zip": "72202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jeff Flowers",
                            "role": "CONTACT",
                            "email": "FlowersJB@archildrens.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.74648,
                        "lon": -92.28959
                    }
                },
                {
                    "facility": "Stanford University",
                    "status": "RECRUITING",
                    "city": "Palo Alto",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Elidia Tafoya",
                            "role": "CONTACT",
                            "email": "etafoya@stanford.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.44188,
                        "lon": -122.14302
                    }
                },
                {
                    "facility": "Minnesota Clinical Study Center",
                    "status": "RECRUITING",
                    "city": "Fridley",
                    "state": "Minnesota",
                    "zip": "55432",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 45.08608,
                        "lon": -93.26328
                    }
                },
                {
                    "facility": "Vascular Birthmark Institute",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Cincinnati Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45229",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Oregon Health and Science University",
                    "status": "RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97239",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Chloe Vignola",
                            "role": "CONTACT",
                            "phone": "503-418-9045",
                            "email": "vignola@ohsu.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                },
                {
                    "facility": "Children's Hospital of Pennsylvania (CHOP)",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "35852876",
                    "type": "DERIVED",
                    "citation": "Teng JMC, Hammill A, Martini J, Treat J. Sirolimus in the Treatment of Microcystic Lymphatic Malformations: A Systematic Review. Lymphat Res Biol. 2023 Apr;21(2):101-110. doi: 10.1089/lrb.2021.0103. Epub 2022 Jul 18."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008202",
                    "term": "Lymphangioma"
                },
                {
                    "id": "D000044148",
                    "term": "Lymphatic Abnormalities"
                },
                {
                    "id": "D000000013",
                    "term": "Congenital Abnormalities"
                }
            ],
            "ancestors": [
                {
                    "id": "D000018190",
                    "term": "Lymphatic Vessel Tumors"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "asFound": "Malformations",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11199",
                    "name": "Lymphangioma",
                    "asFound": "Lymphatic Malformations",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25277",
                    "name": "Lymphatic Abnormalities",
                    "asFound": "Lymphatic Malformations",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T3529",
                    "name": "Lymphatic Malformations",
                    "asFound": "Lymphatic Malformations",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3790",
                    "name": "Microcystic Lymphatic Malformation",
                    "asFound": "Microcystic Lymphatic Malformations",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M21960",
                    "name": "Sirolimus",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}